A federal judge has allowed genetic testing company Illumina
Inc to add a newly issued patent to its lawsuit against rival
Qiagen NV, rejecting Qiagen's argument that it would be
prejudiced by the move.
The ruling, from U.S. District Judge William Alsup in San
Francisco on Tuesday, comes as Qiagen is appealing a preliminary
injunction blocking it from selling its GeneReader
gene-sequencing device. Alsup gave Illumina until Dec. 17 to
amend its complaint.
To read the full story on Westlaw Practitioner Insights,
click here: bit.ly/2gHE1OU